These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10493956)

  • 1. Survival and prognostic factors in lung cancer patients treated in phase I trials: Japanese experience.
    Yamamoto N; Tamura T; Fukuoka M; Saijo N
    Int J Oncol; 1999 Oct; 15(4):737-41. PubMed ID: 10493956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study on prognostic factors in young and old lung cancer patients under chemo-radiotherapy].
    Chen TF; Jiang GL; Fu XL; Wang LJ; Qian H; Zhao S
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):692-6. PubMed ID: 15777511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers.
    Mani S; Todd MB; Katz K; Poo WJ
    J Urol; 1995 Jul; 154(1):35-40. PubMed ID: 7539867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation.
    Osterlind K; Andersen PK
    Cancer Res; 1986 Aug; 46(8):4189-94. PubMed ID: 3015384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression.
    Lassen UN; Osterlind K; Hirsch FR; Bergman B; Dombernowsky P; Hansen HH
    Br J Cancer; 1999 Feb; 79(3-4):515-9. PubMed ID: 10027322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of prognostic factors of survival in patients with unresectable non-small cell lung cancer].
    Muraki M; Toda Y; Haraguchi R; Sugihara R; Kubo H; Nakajima S
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):585-92. PubMed ID: 1849389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
    Asmis TR; Ding K; Seymour L; Shepherd FA; Leighl NB; Winton TL; Whitehead M; Spaans JN; Graham BC; Goss GD;
    J Clin Oncol; 2008 Jan; 26(1):54-9. PubMed ID: 18165640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group study.
    Christodolou C; Pavlidis N; Samantas E; Fountzilas G; Kouvatseas G; Pagdatoglou K; Palamidas F; Nikolaidis C; Angelidou M; Kalofonos HP; Kosmidis P; Skarlos DV
    Anticancer Res; 2002; 22(6B):3749-57. PubMed ID: 12552988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for response and prognostic factors for long-term survival in consecutive, single institution patients with locally advanced and/or metastatic transitional cell carcinoma following cisplatin-based chemotherapy.
    Jessen C; Agerbaek M; Von Der Maase H
    Acta Oncol; 2009; 48(3):411-7. PubMed ID: 18798018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma.
    Motzer RJ; Bacik J; Schwartz LH; Reuter V; Russo P; Marion S; Mazumdar M
    J Clin Oncol; 2004 Feb; 22(3):454-63. PubMed ID: 14752067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
    Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer chemotherapy. Response-survival relationship depends on the method of chest tumor response evaluation.
    Pujol JL; Parrat E; Lehmann M; Gautier V; Daurès JP; Michel FB; Godard P
    Am J Respir Crit Care Med; 1996 Jan; 153(1):243-9. PubMed ID: 8542123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.
    Wakelee HA; Bernardo P; Johnson DH; Schiller JH
    Cancer; 2006 May; 106(10):2208-17. PubMed ID: 16604529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
    Milman N; Pedersen LM
    Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck.
    Argiris A; Li Y; Forastiere A
    Cancer; 2004 Nov; 101(10):2222-9. PubMed ID: 15452834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in small cell lung cancer: multivariate analysis in the National Cancer Center Hospital (Japan).
    Shinkai T; Sakurai M; Eguchi K; Sasaki Y; Tamura T; Fujiwara Y; Fukuda M; Yamada K; Kojima A; Sasaki S
    Jpn J Clin Oncol; 1989 Jun; 19(2):135-41. PubMed ID: 2543848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raised serum urea predicts for early death in small cell lung cancer.
    Winter MC; Potter VA; Woll PJ
    Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):745-50. PubMed ID: 18845424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.
    Stathopoulos GP; Dafni UG; Malamos NA; Rigatos S; Kouvatseas G; Moschopoulos N
    Anticancer Res; 1999; 19(4C):3543-8. PubMed ID: 10629650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current outcome in patients with lung cancer and positive mediastinoscopy.
    Rooker S; Van Schil P; Van den Brande F; De Maeseneer M
    Acta Chir Belg; 2001; 101(6):273-6. PubMed ID: 11868502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
    Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
    Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.